As cancer cells have been shown to be more sensitive to p53 induced apoptosis than normal cells, it has been suggested that administering MDM2 inhibitors in frequent small doses might circumvent apoptosis in healthy cells, but induce cell death in cancer cells [143]. Here, MDM2 is linked to cancer.